CLINICAL_TRIALS ClinicalTrials.gov record update

Post-authorization, Observational Study to Evaluate the Effectiveness of Adalimumab (HUMIRA®) on Moderate-severe Psoriasis Under Conditions of Routine Clinical Practice in Spain.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01076192
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:02.095249+00:00
Published At: 2016-01-06T00:00:00+00:00
Record Updated At: 2016-01-06
Results Posted At: 2016-01-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Moderate-to-severe Chronic Plaque Psoriasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-01-06"
protocolSection.identificationModule.nctId: "NCT01076192"
protocolSection.identificationModule.officialTitle: "Post-authorization, Observational Study to Evaluate the Effectiveness of Adalimumab (HUMIRA\u00ae) on Moderate-severe Psoriasis Under Conditions of Routine Clinical Practice in Spain."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-01-06"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.